These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Different Facets of Liquid Biopsy: A Kaleidoscopic View. Eslami-S Z; Cortés-Hernández LE; Cayrefourcq L; Alix-Panabières C Cold Spring Harb Perspect Med; 2020 Jun; 10(6):. PubMed ID: 31548226 [TBL] [Abstract][Full Text] [Related]
3. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges. Seyhan AA Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063215 [TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy: current technology and clinical applications. Nikanjam M; Kato S; Kurzrock R J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847 [TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy: paving a new avenue for cancer research. Kurma K; Eslami-S Z; Alix-Panabières C; Cayrefourcq L Cell Adh Migr; 2024 Dec; 18(1):1-26. PubMed ID: 39219215 [TBL] [Abstract][Full Text] [Related]
6. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time? Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267 [TBL] [Abstract][Full Text] [Related]
7. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs. Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579 [TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy in CNS tumors: Current status & future perspectives. Husain N; Husain A; Mishra S; Srivastava P Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141 [TBL] [Abstract][Full Text] [Related]
9. The potential of liquid biopsy in the management of cancer patients. Markou A; Tzanikou E; Lianidou E Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850 [TBL] [Abstract][Full Text] [Related]
10. Methods for the Detection of Circulating Biomarkers in Cancer Patients. Mondelo-Macía P; Rodríguez-Ces AM; Suárez-Cunqueiro MM; Romay LM Adv Exp Med Biol; 2022; 1379():525-552. PubMed ID: 35761006 [TBL] [Abstract][Full Text] [Related]
11. The potential of liquid biopsies in gastrointestinal cancer. Wu C; Zhang J; Li H; Xu W; Zhang X Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214 [TBL] [Abstract][Full Text] [Related]
12. Quantitative and Qualitative Analysis of Blood-based Liquid Biopsies to Inform Clinical Decision-making in Prostate Cancer. Casanova-Salas I; Athie A; Boutros PC; Del Re M; Miyamoto DT; Pienta KJ; Posadas EM; Sowalsky AG; Stenzl A; Wyatt AW; Mateo J Eur Urol; 2021 Jun; 79(6):762-771. PubMed ID: 33422353 [TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy in gastric cancer: predictive and prognostic biomarkers. Zhang Z; Wu H; Chong W; Shang L; Jing C; Li L Cell Death Dis; 2022 Oct; 13(10):903. PubMed ID: 36302755 [TBL] [Abstract][Full Text] [Related]
14. Molecular Profiling of Liquid Biopsies for Precision Oncology. Gonzalez-Kozlova EE Adv Exp Med Biol; 2022; 1361():235-247. PubMed ID: 35230692 [TBL] [Abstract][Full Text] [Related]
15. Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine. Bao Y; Zhang D; Guo H; Ma W Cancer Sci; 2024 Apr; 115(4):1060-1072. PubMed ID: 38308498 [TBL] [Abstract][Full Text] [Related]
16. Application of liquid biopsy in precision medicine: opportunities and challenges. Wang J; Chang S; Li G; Sun Y Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793 [TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer. Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913 [TBL] [Abstract][Full Text] [Related]
18. Incorporating liquid biopsies into treatment decision-making: obstacles and possibilities. Beije N; Martens JWM; Sleijfer S Drug Discov Today; 2019 Sep; 24(9):1715-1719. PubMed ID: 31170504 [TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA. Giannopoulou L; Kasimir-Bauer S; Lianidou ES Clin Chem Lab Med; 2018 Jan; 56(2):186-197. PubMed ID: 28753534 [TBL] [Abstract][Full Text] [Related]
20. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management. Fici P Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]